- 183
- 22 623
VitalTransformation
เข้าร่วมเมื่อ 4 ก.ย. 2013
The team at Vital Transformation understands the implications of new medical procedures and technologies. We measure their impact on current clinical practices in close collaboration with health care professionals, researchers, and regulators. The research findings of Vital Transformation have been presented at conferences sponsored by The Royal College of Physicians, The European Commission, The British Embassy -- Belgium, London Genetics, The European Science Foundation, The European Microelectronics Summit, and others. Our clients include many of the world's leading health care organisations.
Addressing Europe's Health Challenges: Innovation, Prevention, and Policy
Join us at the Gastein Health Conference for an insightful conversation on Europe's healthcare challenges and innovations! Host Duane Schulthess sits down with experts like Josep Figueras, the Founder and Director of the European Observatory on Health Systems and Policy, Francesca Colombo, the Head of the OECD Health Division, and Annemiek Verkamman, the Managing Director of HollandBIO, to tackle the EU's pressing healthcare issues. From aging populations and non-communicable diseases to data-driven health innovations, they explore how policy, technology, and cross-border collaboration can enhance Europe's healthcare resilience. Tune in for a deep dive into the future of health in Europe!
See omnystudio.com/listener (omnystudio.com/listener) for privacy information.
See omnystudio.com/listener (omnystudio.com/listener) for privacy information.
มุมมอง: 8
วีดีโอ
The Future of Biotech: Steve Potts on Innovation, Policy, and the Impact of the IRA
มุมมอง 100หลายเดือนก่อน
In this episode of the Vital Health podcast, host Duane Schulthess sits down with Steve Potts, a seasoned entrepreneur and CEO of SLAM BioTherapeutics. They dive deep into the challenges and opportunities in biotech, exploring how recent legislative changes, like the IRA, are reshaping the industry. Steve shares insights on the shift from small molecules to biologics, the funding landscape, and...
The Future of Biotech: Steve Potts on Innovation, Policy, and the Impact of the IRA
มุมมอง 22หลายเดือนก่อน
In this episode of the Vital Health podcast, host Duane Schulthess sits down with Steve Potts, a seasoned entrepreneur and CEO of SLAM BioTherapeutics. They dive deep into the challenges and opportunities in biotech, exploring how recent legislative changes, like the IRA, are reshaping the industry. Steve shares insights on the shift from small molecules to biologics, the funding landscape, and...
Revolutionizing Healthcare with Real-World Data
มุมมอง 34หลายเดือนก่อน
In the latest episode of the Vital Health podcast, we delve into the future of healthcare with Blythe Adamson from Flatiron Health. Learn how Flatiron is at the forefront of transforming drug discovery through real-world data-using insights from everyday clinical practices to drive innovation and improve patient outcomes.Blythe shares fascinating insights on the role of AI in healthcare, statin...
Revolutionizing Healthcare with Real-World Data
มุมมอง 146หลายเดือนก่อน
In the latest episode of the Vital Health podcast, we delve into the future of healthcare with Blythe Adamson from Flatiron Health. Learn how Flatiron is at the forefront of transforming drug discovery through real-world data-using insights from everyday clinical practices to drive innovation and improve patient outcomes. Blythe shares fascinating insights on the role of AI in healthcare, stati...
Exploring the Intersection of Intellectual Property and Biotech Innovation
มุมมอง 15หลายเดือนก่อน
In the latest episode of the Vital Health podcast, we engage in a thought-provoking discussion with Hans Sauer, Deputy General Counsel for Intellectual Property at the Biotechnology Innovation Organization (BIO), and Gwen O'Loughlin, a seasoned health data researcher. Together, they unpack the complexities of intellectual property (IP) in the rapidly evolving biotech landscape. Hans and Gwen sh...
Exploring the Intersection of Intellectual Property and Biotech Innovation
มุมมอง 71หลายเดือนก่อน
In the latest episode of the Vital Health podcast, we engage in a thought-provoking discussion with Hans Sauer, Deputy General Counsel for Intellectual Property at the Biotechnology Innovation Organization (BIO), and Gwen O'Loughlin, a seasoned health data researcher. Together, they unpack the complexities of intellectual property (IP) in the rapidly evolving biotech landscape. Hans and Gwen sh...
Unlocking the Power of Genomic Data: NashBIO's Role in Healthcare Innovation
มุมมอง 24หลายเดือนก่อน
In this episode of the Vital Health podcast, we dive deep into the world of genomic data and its transformative impact on healthcare. Join host Duane Schulthess as he sits down with Judsen Schneider, CTO of Nashville Biosciences, and Curt Allen, VP of Sales, to explore the origins and growth of Nashville Biosciences. Discover how this pioneering company, in collaboration with Vanderbilt Univers...
Unlocking the Power of Genomic Data: NashBIO's Role in Healthcare Innovation
มุมมอง 12หลายเดือนก่อน
In this episode of the Vital Health podcast, we dive deep into the world of genomic data and its transformative impact on healthcare. Join host Duane Schulthess as he sits down with Judsen Schneider, CTO of Nashville Biosciences, and Curt Allen, VP of Sales, to explore the origins and growth of Nashville Biosciences. Discover how this pioneering company, in collaboration with Vanderbilt Univers...
MEP Pernille Weiss - Rapporteur of the EU GPL
มุมมอง 162 หลายเดือนก่อน
In this Vital Health Podcast, Duane Schulthess speaks to Pernille Weiss, a former Member of the European Parliament and the Rapporteur of the European Parliament’s revision of the EU's General Pharmaceutical Legislation (GPL). The GPL proposes many profound changes to the regulatory structures of the EU’s pharmaceutical sector, and MEP Weiss sat at the centre of the European Parliament’s revisi...
Transforming Health Communications: Insights from Virginia Amann
มุมมอง 212 หลายเดือนก่อน
Join us at the International 2024 BIO conference as host Duane Schulthess sits down with Virginia Amann, CEO of the Entente Network. Discover how Virginia has led her firm to become a global leader in strategic communications, crisis management, and behavior science. They discussed the firm's mission to secure positive outcomes for clients, the importance of social capital, and the evolving lan...
Joe Panetta - Policy Impacts on California Biopharma
มุมมอง 203 หลายเดือนก่อน
With the continuing pressure placed upon the US biopharma sector from Washington DC, how is the California biopharma ecosystem, arguably the leading hub for innovative biotech worldwide, responding? In this Vital Health Podcast, we speak with Joseph Panetta to discuss this issue. Joe is the President & CEO of Biocom California, an organization representing over 1,800 members working in Californ...
Joe Panetta - Policy Impacts on California Biopharma
มุมมอง 533 หลายเดือนก่อน
With the continuing pressure placed upon the US biopharma sector from Washington DC, how is the California biopharma ecosystem, arguably the leading hub for innovative biotech worldwide, responding? In this Vital Health Podcast, we speak with Joseph Panetta to discuss this issue. Joe is the President & CEO of Biocom California, an organization representing over 1,800 members working in Californ...
Niklas Blomberg, Executive Director, EU Innovative Health Initiative
มุมมอง 1394 หลายเดือนก่อน
In this Vital Health Podcast, recorded live at the 2024 Bio International Conference, host Duane Schulthess sits down with Niklas Blomberg, the Executive Director of the EU Innovative Health Initiative (IHI). Together, they delve into the transformative journey from the Innovative Medicines Initiative to the broader, more inclusive Innovative Health Initiative. Niklas shares his perspectives on...
Niklas Blomberg, Executive Director, EU Innovative Health Initiative
มุมมอง 64 หลายเดือนก่อน
In this Vital Health Podcast, recorded live at the 2024 Bio International Conference, host Duane Schulthess sits down with Niklas Blomberg, the Executive Director of the EU Innovative Health Initiative (IHI). Together, they delve into the transformative journey from the Innovative Medicines Initiative to the broader, more inclusive Innovative Health Initiative. Niklas shares his perspectives on...
Early Bird: 1 + 1 = 3? Discussing combination therapies, access, innovation and patient benefit
มุมมอง 4711 หลายเดือนก่อน
Early Bird: 1 1 = 3? Discussing combination therapies, access, innovation and patient benefit
PBM rebates are damaging the biopharma ecosystem and public trust - Amitabh Chandra
มุมมอง 61ปีที่แล้ว
PBM rebates are damaging the biopharma ecosystem and public trust - Amitabh Chandra
After the Council cancer screening recommendations: How can we close the early care gap in Europe?
มุมมอง 50ปีที่แล้ว
After the Council cancer screening recommendations: How can we close the early care gap in Europe?
Unifying Generations: Building the Pathway to Intergenerational Solidarity - 21 June 2022, Brussels
มุมมอง 1392 ปีที่แล้ว
Unifying Generations: Building the Pathway to Intergenerational Solidarity - 21 June 2022, Brussels
Early Bird: Double Hardship: Interrupted Care for Ukrainian Cancer Patients13 April, 8.30 CET
มุมมอง 232 ปีที่แล้ว
Early Bird: Double Hardship: Interrupted Care for Ukrainian Cancer Patients13 April, 8.30 CET
Ever closer Union for cancer patients? How to facilitate access to clinical trials across borders?
มุมมอง 852 ปีที่แล้ว
Ever closer Union for cancer patients? How to facilitate access to clinical trials across borders?
Cancer Inequalities between and within Member States - 15 December 2021
มุมมอง 572 ปีที่แล้ว
Cancer Inequalities between and within Member States - 15 December 2021
Diagnosed but not treated? Prioritizing timely care in Europe’s cancer plans - 13 Oct 2021
มุมมอง 1283 ปีที่แล้ว
Diagnosed but not treated? Prioritizing timely care in Europe’s cancer plans - 13 Oct 2021
Improving patient safety: why perioperative care and effective monitoring matters
มุมมอง 2103 ปีที่แล้ว
Improving patient safety: why perioperative care and effective monitoring matters
13 years after Slovenia’s conclusions on cancer: Getting to the next levelThursday, 20 May 2021
มุมมอง 313 ปีที่แล้ว
13 years after Slovenia’s conclusions on cancer: Getting to the next levelThursday, 20 May 2021
Taking the next step: health literacy and the fight against cancer 14 April, 2020, 8:30 - 9:30 CET
มุมมอง 823 ปีที่แล้ว
Taking the next step: health literacy and the fight against cancer 14 April, 2020, 8:30 - 9:30 CET
Cancer care during a pandemic - what have we learned so far?
มุมมอง 693 ปีที่แล้ว
Cancer care during a pandemic - what have we learned so far?
Europe’s Beating Cancer Plan:Why we need it now10 Feb, 2021
มุมมอง 1313 ปีที่แล้ว
Europe’s Beating Cancer Plan:Why we need it now10 Feb, 2021
Cancer prevention: what’s worth the effort?24 November 2020
มุมมอง 2163 ปีที่แล้ว
Cancer prevention: what’s worth the effort?24 November 2020
EHDEN What could the pharma industry look like by 2030?
มุมมอง 1444 ปีที่แล้ว
EHDEN What could the pharma industry look like by 2030?
Anderson Patricia Martin George Moore Brian
The greatest of all time
Very nice event and some illuminating discussion. Thanks for organising.
boom mooom
Lithuania kills its citizens silently Being slightly ill in Lithuania can mean being sentenced to death because of the negligence of the authorities. Lithuania violates human rights by not providing its citizens proper medical care even they have paid for their social insurance. Tests and other medical investigations are carried out in a sequence with long gaps taking weeks or even months between procedures. There is no immediate complex approach to the treatment. This results in progressing health disorders and delaying necessary medical attention. Medical personnel is tied up in bureaucratic red tape. Human Rights Watch and other human rights organizations around the world should take note of what is really happening in the European Union.